News

Investment Plan for Europe – Successful launch of Tech Transfer Fund “KHAN-I”

An ERC Proof of Concept Grant has been awarded to IMP Group Leader Johannes Zuber. The funds will be used towards the development of a diagnostic platform for probing drug responses in cancer cells.

Fokus Krebstherapie: Aktuelle Forschungsergebnisse und Rolle der Kommunikation

Nabriva Therapeutics Earns $5 Million Milestone Payment under its License Agreement with Sinovant Sciences

Multidrug-resistant bacteria: urban brown rats as possible source

18 Teams wurden für den Gründerpreis PHÖNIX nominiert